ADCY10 and neoplasm: Other genes such as KL, MNX1, HMCN1 and ADCY10 suggest that anoikis resistance is not restricted to survival pathways but also extends to metabolic and proliferative mechanisms that drive both tumour aggressiveness and treatment resistance [42–45].